Oncology Business Management | Specialty

The OncLive Oncology Business Management condition center page is a comprehensive resource for news and expert insights on business-focused updates and topics in oncology practices, including diversity efforts, telehealth, gaps in care, payment models, and more. This page features news articles, interviews in written and video format, and podcasts that focus on updates and best practices with oncology business management.

Evolving Role of Genomic Testing in RCC

March 19th 2014

Case Study: Utilizing Multiple Therapies in mRCC

March 19th 2014

Drug Holidays in Renal Cell Carcinoma

March 19th 2014

Case Study: Observation in Metastatic RCC

March 19th 2014

Case Study: Treating Progressive Renal Cell Carcinoma

March 19th 2014

Second-Line Angiogenesis Inhibition in mRCC

March 19th 2014

Second-Line Treatment of Metastatic Renal Cell Carcinoma

March 19th 2014

Optimizing the Upfront Treatment of mRCC

March 19th 2014

Cytoreductive Nephrectomy in Untreated Metastatic RCC

March 19th 2014

Frontline Treatment of Poor-Risk mRCC

March 19th 2014

Treatment of Metastatic Non-Clear Cell RCC

March 19th 2014

Introduction: Multidisciplinary Frontline Treatment of mRCC

March 19th 2014

Health Information Exchanges: Some Community Practices Are Benefitting, Many Are Not

March 19th 2014

Electronic health information exchange (HIE) continues to grow, but only in certain areas of the country and only within certain health systems and practices

Dr. Schneiderman on Cancer Drugs and Futility Policies

March 18th 2014

Lawrence J. Schneiderman, MD, professor emeritus, Medicine/Family & Preventive Medicine, University of California, San Diego (UCSD), discusses futility policies in relation to cancer drugs.

AHRQ Report Says Evaluating Survivorship Programs Difficult Because of 'Idiosyncrasies'

March 18th 2014

Efforts to evaluate cancer survivorship programs are a daunting task according to a technical brief issued by the Agency for Healthcare Research and Quality.

Amended SGR Bill Passes House, But Senate Approval Doubtful

March 17th 2014

After months of wrangling, a call for a vote by House Majority Leader Eric Cantor on an amended version of the Sustainable Growth Rate (SGR) Repeal and Medicare Provider Payment Modernization Act of 2014 (H.R. 4015).

Study: Information and Financial Losses Expected With ICD-10 Transition

March 13th 2014

Converting from ICD-9 to ICD-10 will result in information and financial losses to providers, report researchers from the University of Illinois at Chicago

FDA Tells Direct-to-Consumer Genetic Testing Company to Halt Marketing

March 12th 2014

Federal regulators have ordered the direct-to-consumer genetic testing company 23andMe to stop marketing its saliva-based test without necessary approvals as a medical device

FDA Asks Geron to Halt Imetelstat Development

March 12th 2014

The FDA has placed a full clinical hold on the development of the investigational telomerase inhibitor imetelstat following concerns over consistent low-grade liver function test (LFT) abnormalities

The Promise of ACOs and Bundled Payments Remains Cloudy

March 12th 2014

Evidence that demonstrates how best to implement newer value-based purchasing (VBP) programs like accountable care organizations (ACOs) and bundled payments is lacking